Antitumor activity of Cratylia mollis lectin encapsulated into liposomes

被引:64
作者
Andrade, CAS
Correia, MTS
Coelho, LCBB
Nascimento, SC
Santos-Magalhaes, NS
机构
[1] Univ Fed Pernambuco, LIKA, Grp Sistemas Liberacao Controlada Medicamentos, BR-50670901 Recife, PE, Brazil
[2] UPFE, Dept Bioquim, Lab Glicoprot, BR-50670901 Recife, PE, Brazil
[3] UPFE, Dept Antibiot, BR-50670901 Recife, PE, Brazil
关键词
lectin; Cratylia mollis; liposomes; cytotoxicity; antitumor activity;
D O I
10.1016/j.ijpharm.2004.03.028
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The hemagglutinating (HA) activity of Cratylia mollis lectin (Cra) was evaluated and the influence of ultrasound and mechanical agitation on its activity examined. The antitumor activity of Cra-loaded liposomes was also investigated. Liposomes were obtained by the lipid thin film method. Physicochemical characterization was carried out and long-term stability of Cra-loaded liposomes assessed. Antitumor activity of Cra-loaded liposomes was investigated against Sarcoma 180 in Swiss mice. The treatment was performed intraperitoneally (7 mg/kg body weight per day) for 7 days. Histopathological analyses of tumor, liver, spleen and kidneys were carried out after treatment of the animals. The results showed that Cra-HA activity is affected under ultrasound exposure. However, Cra was successfully encapsulated into liposomes and the activity of the lectin was preserved despite the use of ultrasound in the liposome preparation. Cra-loaded liposomes were produced with an 84% encapsulation ratio (700 mug/ml) and a tumor inhibition of 71% was achieved. The encapsulation of Cra produced a decrease in its tissue toxicity and improved its antitumor activity. In particular, histopathological analysis revealed that treatment with Cra-loaded liposomes prevented Cra cytotoxicity in the liver and kidney of animals. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:435 / 445
页数:11
相关论文
共 27 条
  • [1] OPTIMIZATION AND UPSCALING OF DOXORUBICIN-CONTAINING LIPOSOMES FOR CLINICAL USE
    AMSELEM, S
    GABIZON, A
    BARENHOLZ, Y
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1990, 79 (12) : 1045 - 1052
  • [2] [Anonymous], 1986, LECTINS PROPERTIES F
  • [3] [Anonymous], [No title captured]
  • [4] Barratt, 2000, Pharm Sci Technol Today, V3, P163
  • [5] Cratylia mollis lectin at the air-aqueous solution interface:: adsorption and lectin-lipid interactions
    Baszkin, A
    Boissonnade, MM
    Santos-Magalhaes, NS
    Carvalho, LB
    Correia, MTS
    Coelho, LCBB
    [J]. COLLOIDS AND SURFACES B-BIOINTERFACES, 2000, 17 (03) : 191 - 201
  • [6] Binding evaluation of isoform 1 from Cratylia mollis lectin to human mammary tissues
    Beltrao, EIC
    Correia, MTS
    Figueredo-Silva, J
    Coelho, LCBB
    [J]. APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, 1998, 74 (03) : 125 - 134
  • [7] A liposome-based model system for the simulation of lectin-induced cell adhesion
    Bendas, G
    Vogel, J
    Bakowski, U
    Krause, A
    Muller, J
    Rothe, U
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1997, 1325 (02): : 297 - 308
  • [8] Purification of a glucose mannose specific lectin, isoform 1, from seeds of Cratylia mollis Mart (Camaratu bean)
    Correia, MTS
    Coelho, LCBB
    [J]. APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, 1995, 55 (03) : 261 - 273
  • [9] Ligand-targeted liposomes
    Forssen, E
    Willis, M
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 1998, 29 (03) : 249 - 271
  • [10] FROM ILL-DEFINED EXTRACTS TO THE IMMUNOMODULATORY LECTIN - WILL THERE BE A REASON FOR ONCOLOGICAL APPLICATION OF MISTLETOE
    GABIUS, HJ
    GABIUS, S
    JOSHI, SS
    KOCH, B
    SCHROEDER, M
    MANZKE, WM
    WESTERHAUSEN, A
    [J]. PLANTA MEDICA, 1994, 60 (01) : 2 - 7